[Cytochemical investigation of glycogen in neutrophils of peripheral blood in patients with purulent surgical complications after the application of the myramistin laserophoresis].
In experimental and clinical investigations it was established, that purulent surgical complications are glycogendepending energy-expending process. The diagram of the surgical complications treatment was proposed, which uses laserophoresis of 0.01% aqueous solution of myramistin, securing intracellular glycogen in neutrophils of peripheric blood. Along with the tissue cellular energy-capacity it may be a ground for the myramistin application in complex of treatment of surgical complications.
Gordienko
A I
AI
D000891:Anti-Infective Agents, Local / Q000627:therapeutic use*; D001548:Benzalkonium Compounds / Q000493:pharmacokinetics* / Q000627:therapeutic use*; D002462:Cell Membrane / Q000378:metabolism; D006003:Glycogen / Q000378:metabolism*; D006651:Histocytochemistry / Q000379:methods; D006801:Humans; D053685:Laser Therapy; D009504:Neutrophils / Q000378:metabolism*; D017893:Photopheresis / Q000295:instrumentation; D013492:Suppuration / Q000628:therapy; D013530:Surgical Wound Infection / Q000378:metabolism* / Q000628:therapy*; D013997:Time Factors
D000891:Anti-Infective Agents, Local; D001548:Benzalkonium Compounds; D006003:Glycogen; C058048:miramistin